Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.05 on 星期二, after dropping 37.50%
On the latest trading day Jan 27, 2026, the stock price of BBIXF fell by 37.50%, dropping from $0.05 to $0.05. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.05 and a high of $0.05. On the latest trading day, the trading volume for BBIXF rose by 6.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 10.0K shares were traded, with a market value of approximately $58.3M.